Copyright Reports & Markets. All rights reserved.

Global Cancer Supportive Care Medicine Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Cancer Supportive Care Medicine Market Overview

      • 1.1 Product Overview and Scope of Cancer Supportive Care Medicine
      • 1.2 Cancer Supportive Care Medicine Segment by Type
        • 1.2.1 Global Cancer Supportive Care Medicine Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Antiemetic Drugs
        • 1.2.3 Erythropoietin-Stimulating Agents
        • 1.2.4 Granulocyte-Stimulating Agents
        • 1.2.5 Analgesics
        • 1.2.6 Others
      • 1.3 Cancer Supportive Care Medicine Segment by Application
        • 1.3.1 Cancer Supportive Care Medicine Consumption Comparison by Application (2014-2025)
        • 1.3.2 Chemotherapy-Induced Anemia
        • 1.3.3 CINV
        • 1.3.4 Bone Metastasis
        • 1.3.5 Cancer Pain
        • 1.3.6 Other
      • 1.3 Global Cancer Supportive Care Medicine Market by Region
        • 1.3.1 Global Cancer Supportive Care Medicine Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Cancer Supportive Care Medicine Market Size
        • 1.4.1 Global Cancer Supportive Care Medicine Revenue (2014-2025)
        • 1.4.2 Global Cancer Supportive Care Medicine Production (2014-2025)

      2 Global Cancer Supportive Care Medicine Market Competition by Manufacturers

      • 2.1 Global Cancer Supportive Care Medicine Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Cancer Supportive Care Medicine Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Cancer Supportive Care Medicine Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Cancer Supportive Care Medicine Production Sites, Area Served, Product Types
      • 2.5 Cancer Supportive Care Medicine Market Competitive Situation and Trends
        • 2.5.1 Cancer Supportive Care Medicine Market Concentration Rate
        • 2.5.2 Cancer Supportive Care Medicine Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Cancer Supportive Care Medicine Production Market Share by Regions

      • 3.1 Global Cancer Supportive Care Medicine Production Market Share by Regions
      • 3.2 Global Cancer Supportive Care Medicine Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Cancer Supportive Care Medicine Production
        • 3.4.1 North America Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
        • 3.4.2 North America Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Cancer Supportive Care Medicine Production
        • 3.5.1 Europe Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
        • 3.5.2 Europe Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Cancer Supportive Care Medicine Production (2014-2019)
        • 3.6.1 China Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
        • 3.6.2 China Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Cancer Supportive Care Medicine Production (2014-2019)
        • 3.7.1 Japan Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
        • 3.7.2 Japan Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Cancer Supportive Care Medicine Consumption by Regions

      • 4.1 Global Cancer Supportive Care Medicine Consumption by Regions
      • 4.2 North America Cancer Supportive Care Medicine Consumption (2014-2019)
      • 4.3 Europe Cancer Supportive Care Medicine Consumption (2014-2019)
      • 4.4 China Cancer Supportive Care Medicine Consumption (2014-2019)
      • 4.5 Japan Cancer Supportive Care Medicine Consumption (2014-2019)

      5 Global Cancer Supportive Care Medicine Production, Revenue, Price Trend by Type

      • 5.1 Global Cancer Supportive Care Medicine Production Market Share by Type (2014-2019)
      • 5.2 Global Cancer Supportive Care Medicine Revenue Market Share by Type (2014-2019)
      • 5.3 Global Cancer Supportive Care Medicine Price by Type (2014-2019)
      • 5.4 Global Cancer Supportive Care Medicine Production Growth by Type (2014-2019)

      6 Global Cancer Supportive Care Medicine Market Analysis by Applications

      • 6.1 Global Cancer Supportive Care Medicine Consumption Market Share by Application (2014-2019)
      • 6.2 Global Cancer Supportive Care Medicine Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Cancer Supportive Care Medicine Business

      • 7.1 Amgen
        • 7.1.1 Amgen Cancer Supportive Care Medicine Production Sites and Area Served
        • 7.1.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
        • 7.1.3 Amgen Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Helsinn Healthcare
        • 7.2.1 Helsinn Healthcare Cancer Supportive Care Medicine Production Sites and Area Served
        • 7.2.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
        • 7.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Johnson &Johnson
        • 7.3.1 Johnson &Johnson Cancer Supportive Care Medicine Production Sites and Area Served
        • 7.3.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
        • 7.3.3 Johnson &Johnson Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Merck
        • 7.4.1 Merck Cancer Supportive Care Medicine Production Sites and Area Served
        • 7.4.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
        • 7.4.3 Merck Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 F. Hoffmann-La Roche
        • 7.5.1 F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Sites and Area Served
        • 7.5.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
        • 7.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 GlaxoSmithKline
        • 7.6.1 GlaxoSmithKline Cancer Supportive Care Medicine Production Sites and Area Served
        • 7.6.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
        • 7.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Heron Therapeutics
        • 7.7.1 Heron Therapeutics Cancer Supportive Care Medicine Production Sites and Area Served
        • 7.7.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
        • 7.7.3 Heron Therapeutics Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Kyowa Hakko Kirin
        • 7.8.1 Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Sites and Area Served
        • 7.8.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
        • 7.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Novartis
        • 7.9.1 Novartis Cancer Supportive Care Medicine Production Sites and Area Served
        • 7.9.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
        • 7.9.3 Novartis Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 TESARO
        • 7.10.1 TESARO Cancer Supportive Care Medicine Production Sites and Area Served
        • 7.10.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
        • 7.10.3 TESARO Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Teva Pharmaceutical Industries

      8 Cancer Supportive Care Medicine Manufacturing Cost Analysis

      • 8.1 Cancer Supportive Care Medicine Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Cancer Supportive Care Medicine
      • 8.4 Cancer Supportive Care Medicine Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Cancer Supportive Care Medicine Distributors List
      • 9.3 Cancer Supportive Care Medicine Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Cancer Supportive Care Medicine Market Forecast

      • 11.1 Global Cancer Supportive Care Medicine Production, Revenue Forecast
        • 11.1.1 Global Cancer Supportive Care Medicine Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Cancer Supportive Care Medicine Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Cancer Supportive Care Medicine Price and Trend Forecast (2019-2025)
      • 11.2 Global Cancer Supportive Care Medicine Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Cancer Supportive Care Medicine Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Cancer Supportive Care Medicine Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Cancer Supportive Care Medicine Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Cancer Supportive Care Medicine Production, Revenue Forecast (2019-2025)
      • 11.3 Global Cancer Supportive Care Medicine Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Cancer Supportive Care Medicine Consumption Forecast (2019-2025)
        • 11.3.2 Europe Cancer Supportive Care Medicine Consumption Forecast (2019-2025)
        • 11.3.3 China Cancer Supportive Care Medicine Consumption Forecast (2019-2025)
        • 11.3.4 Japan Cancer Supportive Care Medicine Consumption Forecast (2019-2025)
      • 11.4 Global Cancer Supportive Care Medicine Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Cancer Supportive Care Medicine Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Cancer Supportive Care Medicine market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Cancer Supportive Care Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Supportive Care Medicine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Amgen
        Helsinn Healthcare
        Johnson &Johnson
        Merck
        F. Hoffmann-La Roche
        GlaxoSmithKline
        Heron Therapeutics
        Kyowa Hakko Kirin
        Novartis
        TESARO
        Teva Pharmaceutical Industries

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Antiemetic Drugs
        Erythropoietin-Stimulating Agents
        Granulocyte-Stimulating Agents
        Analgesics
        Others

        Segment by Application
        Chemotherapy-Induced Anemia
        CINV
        Bone Metastasis
        Cancer Pain
        Other

        Buy now